Aurora Cannabis Inc. (TSE:ACB) Receives C$5.85 Average Price Target from Analysts

Aurora Cannabis Inc. (TSE:ACB) has been given an average recommendation of “Moderate Buy” by the five ratings firms that are currently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and two have given a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is C$7.11.

Several research analysts recently weighed in on the company. Atb Cap Markets raised Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. ATB Capital dropped their price objective on shares of Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. Finally, TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th.

Aurora Cannabis Stock Performance

Shares of ACB opened at C$9.50 on Friday. Aurora Cannabis has a one year low of C$3.84 and a one year high of C$12.85. The company has a 50-day moving average of C$6.18 and a two-hundred day moving average of C$7.18. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. The stock has a market cap of C$519.27 million, a price-to-earnings ratio of -15.08 and a beta of 2.71.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.